Name	Current Price - Today's Change	Market Cap
BAXTER INTERNATIONAL INC (BAX)	$56.38 - $0.02(0.04%)	34.12 B
COVIDIEN PLC (COV)	$49.55 - $0.09(0.18%)	24.60 B
STRYKER CORP (SYK)	$51.91 - $0.48(0.93%)	20.31 B
BECTON; DICKINSON & CO (BDX)	$75.26 - $0.58(0.78%)	17.74 B
INTUITIVE SURGICAL INC (ISRG)	$326.84 - $2.89(0.89%)	12.53 B
BOSTON SCIENTIFIC CORP (BSX)	$8.23 - $0.08(0.98%)	12.40 B
ZIMMER HOLDINGS INC (ZMH)	$56.08 - $0.66(1.19%)	11.81 B
LUXOTTICA GROUP SPA ADR (LUX)	$25.00 - $0.78(3.22%)	11.25 B
SMITH & NEPHEW PLC ADS (SNN)	$50.24 - $1.14(2.32%)	9.31 B
C.R. BARD INC (BCR)	$81.36 - $0.60(0.74%)	7.72 B

STOCK ANALYSIS

Novartis Looks For 20/20 Vision With Alcon (NVS, ACL, AGN, COO)
The Swiss drug maker hopes to take full ownership of Alcon later in the year. Find out what it'll mean for these tw...

A Review Of The Drug Makers Of 2009 (PFE, MRK, BMY)
Corporate deal-making was the name of the big pharma game in 2009 and will likely continue into the new year.

Alcon Takes A Poke In The Eye (ACL, NVS, AZN)
Despite investor worries over Alcon's growth, the eye care company is a proven winner.

Novartis' Eye-Catching Deal Won't Add Value
Novartis is spreading itself too thin with yet another acquisition - this time for vision specialist Alcon.

Capitalizing On Our Candy Cravings (NSRGY, CSG, HSY)
Not all chocolate investments are a sweet deal. We taste test three of the major confectionery conveyors.

View All Stock Analysis

ACL RELATED HEADLINES

Two Pharmas
Featuring Wallace Forbes and Damien Conover.
Forbes.com 2/4/2010

Alcon (ACL) Hits Investors Observer Momentum Plays List
Alcon (NYSE: ACL) closed yesterday at $158.93. So far the stock has hit a 52-week low of $76.03 and 52-week high of $166.71. Alcon stock has been showing support around 154.80 and resistance in the 161.18 range. Technical indicators for the stock are Bullish and S&P gives ACL a neutral 3 STAR (out of 5) hold rating. ACL appears on the Investors Observer Momentum Plays list. For a hedged play on this stock, look at a May '10 165 covered call for a net debit in the $156.28 area. That is also the break even stock price for this trade. This covered call has a 108 day duration, provides 1.67% downsid...
At Market Intelligence Center 2/3/2010

Big Pharma's Best Chief Steps Down
Novartis' Dan Vasella has done better than his peers. Now he is handing over the reins.
Forbes.com 1/26/2010

Britain Sneaks Out Of Recession
European stocks slide as the U.K. just manages to end six consecutive quarters of economic contraction.
Forbes.com 1/26/2010

Alcon (ACL) Makes Investors Observer Momentum Plays List
Alcon (NYSE: ACL) closed yesterday at $154.80. So far the stock has hit a 52-week low of $76.03 and 52-week high of $166.71. Alcon stock has been showing support around 153.17 and resistance in the 156.57 range. Technical indicators for the stock are Bearish and S&P gives ACL a neutral 3 STAR (out of 5) hold rating. ACL appears on the Investors Observer Momentum Plays list. For a hedged play on this stock, look at a Mar '10 160 covered call for a net debit in the $152.90 area. That is also the break even stock price for this trade. This covered call has a 57 day duration, provides 1.23% downside...
At Market Intelligence Center 1/22/2010

Alcon (ACL) Trading In Tight Support/Resistance Range
Alcon (NYSE: ACL) closed yesterday at $153.24. So far the stock has hit a 52-week low of $76.03 and 52-week high of $166.71. Alcon stock has been showing support around 152.09 and resistance in the 154.77 range. Technical indicators for the stock are Bearish and S&P gives ACL a neutral 3 STAR (out of 5) hold rating. ACL appears on the Investors Observer Momentum Plays list. For a hedged play on this stock, look at a May '10 160 covered call for a net debit in the $150.24 area. That is also the break even stock price for this trade. This covered call has a 128 day duration, provides 1.96% downsid...
At Market Intelligence Center 1/14/2010

View All Headlines